Screener
Eligibility screening
Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
5 US sites in MS, NC, NY, UT +1
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.